InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Regeneron Pharmaceuticals

REGN Clue Score47
United States Fiscal year ends December CIK 0000872589
$746.54 +0.94% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $746.54 +36.66% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue4.86Operating income1.33Net income0.90EPS, diluted7.70Fiscal year 2017Revenue5.87 +20.8%Operating income2.08Net income1.20 +33.8%EPS, diluted10.34 +34.3%Fiscal year 2018Revenue5.15 −12.4%Operating income2.53Net income2.44 +104.0%EPS, diluted21.29 +105.9%Fiscal year 2019Revenue6.56 +27.4%Operating income2.21Net income2.12 −13.4%EPS, diluted18.46 −13.3%Fiscal year 2020Revenue8.50 +29.6%Operating income3.58Net income3.51 +66.0%EPS, diluted30.52 +65.3%Fiscal year 2021Revenue16.07 +89.1%Operating income8.95Net income8.08 +129.9%EPS, diluted71.97 +135.8%Fiscal year 2022Revenue12.17 −24.3%Operating income4.74Net income4.34 −46.3%EPS, diluted38.22 −46.9%Fiscal year 2023Revenue13.12 +7.8%Operating income4.05Net income3.95 −8.9%EPS, diluted34.77 −9.0%Fiscal year 2024Revenue14.20 +8.3%Operating income3.99Net income4.41 +11.6%EPS, diluted38.34 +10.3%Fiscal year 2025Revenue14.34 +1.0%Operating income3.58Net income4.50 +2.1%EPS, diluted41.48 +8.2%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 4.86 5.87 5.15 6.56 8.50 16.07 12.17 13.12 14.20 14.34
Growth +20.8% −12.4% +27.4% +29.6% +89.1% −24.3% +7.8% +8.3% +1.0%
Operating income 1.33 2.08 2.53 2.21 3.58 8.95 4.74 4.05 3.99 3.58
Net income 0.90 1.20 2.44 2.12 3.51 8.08 4.34 3.95 4.41 4.50
Growth +33.8% +104.0% −13.4% +66.0% +129.9% −46.3% −8.9% +11.6% +2.1%
EPS, diluted 7.70 10.34 21.29 18.46 30.52 71.97 38.22 34.77 38.34 41.48
Growth +34.3% +105.9% −13.3% +65.3% +135.8% −46.9% −9.0% +10.3% +8.2%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Operating margin27.4%Net margin18.4%Free cash flow margin20.0%Fiscal year 2017Operating margin35.4%Net margin20.4%Free cash flow margin17.6%Fiscal year 2018Operating margin49.3%Net margin47.5%Free cash flow margin35.2%Fiscal year 2019Operating margin33.7%Net margin32.3%Free cash flow margin30.5%Fiscal year 2020Operating margin42.1%Net margin41.3%Free cash flow margin23.6%Fiscal year 2021Operating margin55.7%Net margin50.2%Free cash flow margin40.6%Fiscal year 2022Operating margin38.9%Net margin35.6%Free cash flow margin36.3%Fiscal year 2023Operating margin30.9%Net margin30.1%Free cash flow margin29.5%Fiscal year 2024Operating margin28.1%Net margin31.1%Free cash flow margin25.8%Fiscal year 2025Operating margin24.9%Net margin31.4%Free cash flow margin28.4%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin 27.4% 35.4% 49.3% 33.7% 42.1% 55.7% 38.9% 30.9% 28.1% 24.9%
Net margin 18.4% 20.4% 47.5% 32.3% 41.3% 50.2% 35.6% 30.1% 31.1% 31.4%
Free cash flow margin 20.0% 17.6% 35.2% 30.5% 23.6% 40.6% 36.3% 29.5% 25.8% 28.4%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow1.49Capital expenditure−0.51Free cash flow0.97Buybacks0.00Fiscal year 2017Operating cash flow1.31Capital expenditure−0.27Free cash flow1.03 +6.2%Buybacks0.00Fiscal year 2018Operating cash flow2.20Capital expenditure−0.38Free cash flow1.81 +75.2%Buybacks−0.00Fiscal year 2019Operating cash flow2.43Capital expenditure−0.43Free cash flow2.00 +10.4%Buybacks−0.28Fiscal year 2020Operating cash flow2.62Capital expenditure−0.61Free cash flow2.00 +0.2%Buybacks−5.85Fiscal year 2021Operating cash flow7.08Capital expenditure−0.55Free cash flow6.53 +225.9%Buybacks−1.65Fiscal year 2022Operating cash flow5.01Capital expenditure−0.59Free cash flow4.42 −32.2%Buybacks−2.08Fiscal year 2023Operating cash flow4.59Capital expenditure−0.72Free cash flow3.88 −12.4%Buybacks−2.24Dividends paid0.00Fiscal year 2024Operating cash flow4.42Capital expenditure−0.76Free cash flow3.66 −5.4%Buybacks−2.60Dividends paid0.00Fiscal year 2025Operating cash flow4.98Capital expenditure−0.90Free cash flow4.08 +11.3%Buybacks−3.44Dividends paid−0.37
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 1.49 1.31 2.20 2.43 2.62 7.08 5.01 4.59 4.42 4.98
Capital expenditure −0.51 −0.27 −0.38 −0.43 −0.61 −0.55 −0.59 −0.72 −0.76 −0.90
Free cash flow 0.97 1.03 1.81 2.00 2.00 6.53 4.42 3.88 3.66 4.08
Growth +6.2% +75.2% +10.4% +0.2% +225.9% −32.2% −12.4% −5.4% +11.3%
Buybacks 0.00 0.00 −0.00 −0.28 −5.85 −1.65 −2.08 −2.24 −2.60 −3.44
Dividends paid n/a n/a n/a n/a n/a n/a n/a 0.00 0.00 −0.37

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash0.54Shareholders’ equity4.45Fiscal year 2017Cash0.81Shareholders’ equity6.14Fiscal year 2018Cash1.47Shareholders’ equity8.76Fiscal year 2019Cash1.62Total debt0.00Net cash (debt)1.62Shareholders’ equity11.09Debt to equity0.00Fiscal year 2020Cash2.19Total debt1.98Net cash (debt)0.22Shareholders’ equity11.03Debt to equity0.18Fiscal year 2021Cash2.89Total debt1.98Net cash (debt)0.91Shareholders’ equity18.77Debt to equity0.11Fiscal year 2022Cash3.11Total debt1.98Net cash (debt)1.12Shareholders’ equity22.66Debt to equity0.09Fiscal year 2023Cash2.73Total debt1.98Net cash (debt)0.75Shareholders’ equity25.97Debt to equity0.08Fiscal year 2024Cash2.49Total debt1.98Net cash (debt)0.50Shareholders’ equity29.35Debt to equity0.07Fiscal year 2025Cash3.12Total debt1.99Net cash (debt)1.13Shareholders’ equity31.26Debt to equity0.06
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 0.54 0.81 1.47 1.62 2.19 2.89 3.11 2.73 2.49 3.12
Total debt n/a n/a n/a 0.00 1.98 1.98 1.98 1.98 1.98 1.99
Net cash (debt) n/a n/a n/a 1.62 0.22 0.91 1.12 0.75 0.50 1.13
Shareholders’ equity 4.45 6.14 8.76 11.09 11.03 18.77 22.66 25.97 29.35 31.26
Debt to equity n/a n/a n/a 0.00 0.18 0.11 0.09 0.08 0.07 0.06

In billions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Cash flow

In billions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Operations
1.49 1.31 2.20 2.43 2.62 7.08 5.01 4.59 4.42 4.98
Growth −12.0% +67.9% +10.7% +7.7% +170.5% −29.2% −8.4% −3.8% +12.6%
0.10 0.15 0.15 0.21 0.24 0.29 0.34 0.42 0.48 0.54
Investment
−0.51 −0.27 −0.38 −0.43 −0.61 −0.55 −0.59 −0.72 −0.76 −0.90
calc 0.97 1.03 1.81 2.00 2.00 6.53 4.42 3.88 3.66 4.08
Growth +6.2% +75.2% +10.4% +0.2% +225.9% −32.2% −12.4% −5.4% +11.3%
calc 8.37 8.93 15.78 17.46 17.41 58.19 38.99 34.08 31.84 37.57
−1.05 −1.01 −1.46 −2.03 −0.07 −5.38 −3.78 −3.19 −2.47 −0.63
Financing
−0.70 −0.02 −0.08 −0.25 −1.97 −1.01 −1.01 −1.79 −2.20 −3.72
n/a n/a n/a n/a n/a n/a n/a 0.00 0.00 −0.37
0.00 0.00 −0.00 −0.28 −5.85 −1.65 −2.08 −2.24 −2.60 −3.44

Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative.